admin

Precision Nutrition Portfolio Kick-off Meeting

Download Draft Agenda

INGREEN (Novel Food Ingredients) Group

INGREEN has over 20 years of experience in bioactive ingredients for the design of novel foods for specific health use. Research activities cover processing, chemical and biological characterization and in vitro evaluation of efficacy. Vegetal sources (plants, spices, seeds, roots or fruits), fungi and edible insects are the main raw materials investigated. Processing is largely INGREEN (Novel Food Ingredients) Group

Functional glycogenomics

The Glycosylation is the most abundant, diverse and dynamic post-translational modification in nature, generating one of the most complex biological molecules found in nature, glycans. The group has devoted the last five years to assemble, implement and validate a novel technological platform that allows to analyze the N-glycome from biological samples just available in a Functional glycogenomics

Mitochondrial Function in Health and Disease Group

Mitochondrial function if a cornerstone of metabolic plasticity, allowing the eukaryotic cell to adapt efficiently to changing energetic demands and nutrient availability. Its role in human physiology is well documented and its dysfunction has been associated with an always increasing number of pathologies. In particular, mitochondria as a source of damaging ROS has been extensively Mitochondrial Function in Health and Disease Group

Physiopathology and Molecular Mechanisms of Obesity and Comorbidities Group

Insulin resistance is an early event in the development of obesity and related comorbidities, including type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). The close relationship between metabolism and the immune system (immunometabolism) plays an essential role in the development of these pathologies. The changes in the intestinal microbiota that occur in Physiopathology and Molecular Mechanisms of Obesity and Comorbidities Group

Hospital Universitario 12 de Octubre Research Team

Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM)

The Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) is a joint institution of CSIC and the Autonomous University of Madrid (UAM), located at UAM-Faculty of Medicine campus and specialized in Biomedicine Research. The research carried out at the IIBM focuses on the study of the molecular basis of human pathology with a translational approach, integrating basic Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM)

EpiDisease Research Group

EpiDisease S.L. is a biotechnology company that identifies, develops and commercialises a pipeline of patented genetic and epigenetic in vitro diagnostic (IVD) products and clinical software tools incorporating AI for the precision management of complex human diseases.

MarBiotech Research Group

MarBiotech is a research group led by João Varela and Luísa Barreira. The focus of the group is the study of microalgae to use them as novel sources of (functional) food and feed, biostimulants, drug leads, while fixating CO2 into biomass and treating effluents from the agroindustry and other sources. The final goal is to MarBiotech Research Group

Platform for clinical trials in nutrition and health (GENYAL) & Precision Nutrition and Cancer Group

The Platform for Clinical Trials in Nutrition and Health (GENYAL) constitutes a high-level scientific tool to assess the biological activity and health properties of food, supplements, targeted nutritional strategies and functional foods, taking into account the specific characteristics of population subgroups. Thus, GENYAL is a specialized platform for clinical trials in Precision Nutrition. GENYAL Platform Platform for clinical trials in nutrition and health (GENYAL) & Precision Nutrition and Cancer Group

Follow us on social networks